Artículos de revistas
Reduced Insulin Clearance And Lower Insulin-degrading Enzyme Expression In The Liver Might Contribute To The Thrifty Phenotype Of Protein-restricted Mice
British Journal Of Nutrition. Cambridge University Press, v. 112, n. 6, p. 900 - 907, 2014.
Nutrient restriction during the early stages of life usually leads to alterations in glucose homeostasis, mainly insulin secretion and sensitivity, increasing the risk of metabolic disorders in adulthood. Despite growing evidence regarding the importance of insulin clearance during glucose homeostasis in health and disease, no information exists about this process in malnourished animals. Thus, in the present study, we aimed to determine the effect of a nutrient-restricted diet on insulin clearance using a model in which 30-d-old C57BL/6 mice were exposed to a protein-restricted diet for 14 weeks. After this period, we evaluated many metabolic variables and extracted pancreatic islet, liver, gastrocnemius muscle (GCK) and white adipose tissue samples from the control (normal-protein diet) and restricted (low-protein diet, LP) mice. Insulin concentrations were determined using RIA and protein expression and phosphorylation by Western blot analysis. The LP mice exhibited lower body weight, glycaemia, and insulinaemia, increased glucose tolerance and altered insulin dynamics after the glucose challenge. The improved glucose tolerance could partially be explained by an increase in insulin sensitivity through the phosphorylation of the insulin receptor/protein kinase B and AMP-activated protein kinase/acetyl-CoA carboxylase in the liver, whereas the changes in insulin dynamics could be attributed to reduced insulin secretion coupled with reduced insulin clearance and lower insulin-degrading enzyme (IDE) expression in the liver and GCK. In summary, protein-restricted mice not only produce and secrete less insulin, but also remove and degrade less insulin. This phenomenon has the double benefit of sparing insulin while prolonging and potentiating its effects, probably due to the lower expression of IDE in the liver, possibly with long-term consequences.1126900907Defronzo, R.A., Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: A balanced overview (1992) Diabetologia, 35, pp. 389-397Remacle, C., Dumortier, O., Bol, V., Intrauterine programming of the endocrine pancreas (2007) Diabetes Obes Metab, 9, pp. 196-209Snoeck, A., Remacle, C., Reusens, B., Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas (1990) Biol Neonate, 57, pp. 107-118Hales, C.N., Barker, D.J., Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis (1992) Diabetologia, 35, pp. 595-601Hales, C.N., Fetal and infant growth and impaired glucose tolerance in adulthood: The "thrifty phenotype" hypothesis revisited (1997) Acta Paediatr Suppl, 422, pp. 73-77Batista, T.M., Ribeiro, R.A., Da Silva, P.M., Taurine supplementation improves liver glucose control in normal protein and malnourished mice fed a high-fat diet (2013) Mol Nutr Food Res, 57, pp. 423-434Cappelli, A.P., Zoppi, C.C., Barbosa-Sampaio, H.C., Taurine-induced insulin signalling improvement of obese malnourished mice is associated with redox balance and protein phosphatases activity modulation (2014) Liver Int, 34, pp. 771-783Camargo, R.L., Batista, T.M., Ribeiro, R.A., Effects of taurine supplementation upon food intake and central insulin signaling in malnourished mice fed on a high-fat diet (2013) Adv Exp Med Biol, 776, pp. 93-103Rafacho, A., Giozzet, V.A., Boschero, A.C., Reduced pancreatic beta-cell mass is associated with decreased FoxO1 and Erk1/2 protein phosphorylation in low-protein malnourished rats (2009) Braz J Med Biol Res, 42, pp. 935-941Araujo, E.P., Amaral, M.E., Filiputti, E., Restoration of insulin secretion in pancreatic islets of protein-deficient rats by reduced expression of insulin receptor substrate (IRS)-1 and IRS-2 (2004) J Endocrinol, 181, pp. 25-38Latorraca, M.Q., Reis, M.A., Carneiro, E.M., Protein deficiency and nutritional recovery modulate insulin secretion and the early steps of insulin action in rats (1998) J Nutr, 128, pp. 1643-1649Reis, M.A., Carneiro, E.M., Mello, M.A., Glucose-induced insulin secretion is impaired and insulin-induced phosphorylation of the insulin receptor and insulin receptor substrate-1 are increased in protein-deficient rats (1997) J Nutr, 127, pp. 403-410Masiello, P., Animal models of type 2 diabetes with reduced pancreatic beta-cell mass (2006) Int J Biochem Cell Biol, 38, pp. 873-893Jolly, M.C., Hovorka, R., Godsland, I., Relation between insulin kinetics and insulin sensitivity in pregnancy (2003) Eur J Clin Invest, 33, pp. 698-703Hales, C.N., Metabolic consequences of intrauterine growth retardation (1997) Acta Paediatr Suppl, 423, pp. 184-187. , (discussion 188)Law, C.M., Fetal and infant influences on non-insulindependent diabetes mellitus (NIDDM) (1996) Diabet Med, 13, pp. S49-S52Hales, C.N., Barker, D.J., The thrifty phenotype hypothesis (2001) Br Med Bull, 60, pp. 5-20Hwang, D.Y., Seo, S., Kim, Y., Significant change in insulin production, glucose tolerance and ER stress signaling in transgenic mice coexpressing insulin-siRNA and human IDE (2007) Int J Mol Med, 19, pp. 65-73Park, S.Y., Cho, Y.R., Kim, H.J., Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1 (2006) Am J Physiol Endocrinol Metab, 291, pp. E517-E524Ahrén, B., Thomaseth, K., Pacini, G., Reduced insulin clearance contributes to the increased insulin levels after administration of glucagon-like peptide 1 in mice (2005) Diabetologia, 48, pp. 2140-2146Meier, J.J., Veldhuis, J.D., Butler, P.C., Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans (2005) Diabetes, 54, pp. 1649-1656Valera Mora, M.E., Scarfone, A., Calvani, M., Insulin clearance in obesity (2003) J Am Coll Nutr, 22, pp. 487-493Mittelman, S.D., Van Citters, G.W., Kim, S.P., Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response (2000) Diabetes, 49, pp. 2116-2125Duckworth, W.C., Bennett, R.G., Hamel, F.G., Insulin degradation: Progress and potential (1998) Endocr Rev, 19, pp. 608-624Boden, G., Ruiz, J., Kim, C.J., Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects (1996) Am J Physiol, 270, pp. E251-E258Butterfield, W.J., Insulin clearance in nondiabetic and diabetic subjects (1970) Panminerva Med, 12, pp. 233-235Authier, F., Posner, B.I., Bergeron, J.J., Insulin-degrading enzyme (1996) Clin Invest Med, 19, pp. 149-160Santos, G.J., Oliveira, C.A., Boschero, A.C., CNTF protects MIN6 cells against apoptosis induced by Alloxan and IL-1b through downregulation of the AMPK pathway (2011) Cell Signal, 23, pp. 1669-1676Rezende, L.F., Vieira, A.S., Negro, A., Ciliary neurotrophic factor (CNTF) signals through STAT3-SOCS3 pathway and protects rat pancreatic islets from cytokine-induced apoptosis (2009) Cytokine, 46, pp. 65-71Rezende, L.F., Stoppiglia, L.F., Souza, K.L., Ciliary neurotrophic factor promotes survival of neonatal rat islets via the BCL-2 anti-apoptotic pathway (2007) J Endocrinol, 195, pp. 157-165Amata, O., Marino, T., Russo, N., Human insulindegrading enzyme working mechanism (2009) J Am Chem Soc, 131, pp. 14804-14811Fernández-Gamba, A., Leal, M.C., Morelli, L., Insulin-degrading enzyme: Structure-function relationship and its possible roles in health and disease (2009) Curr Pharm des, 15, pp. 3644-3655Hulse, R.E., Ralat, L.A., Wei-Jen, T., Structure, function, and regulation of insulin-degrading enzyme (2009) Vitam Horm, 80, pp. 635-648Kuo, W.L., Montag, A.G., Rosner, M.R., Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues (1993) Endocrinology, 132, pp. 604-611Duckworth, W.C., Hamel, F.G., Peavy, D.E., Hepatic metabolism of insulin (1988) Am J Med, 85, pp. 71-76Duckworth, W.C., Insulin degradation: Mechanisms, products, and significance (1988) Endocr Rev, 9, pp. 319-345Yonezawa, K., Yokono, K., Yaso, S., Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments (1986) Endocrinology, 118, pp. 1989-1996Rezende, L.F., Santos, G.J., Santos-Silva, J.C., Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance (2012) Diabetologia, 55, pp. 1495-1504Lu, X., Huang, Y., Liu, Y., Variants in the insulindegrading enzyme gene are associated with metabolic syndrome in Chinese elders (2009) Metabolism, 58, pp. 1465-1469Rudovich, N., Pivovarova, O., Fisher, E., Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes (2009) J Mol Med, 87, pp. 1145-1151Slominskil, P.A., Pivovarova, O.V., Shadrina, M.I., Association of insulinase gene polymorphisms with type 2 diabetes mellitus in patients from the Moscow population (2009) Genetika, 45, pp. 127-131Winkler, C., Illig, T., Koczwara, K., HHEX-IDE polymorphism is associated with low birth weight in offspring with a family history of type 1 diabetes (2009) J Clin Endocrinol Metab, 94, pp. 4113-4115Furukawa, Y., Shimada, T., Furuta, H., Polymorphisms in the IDE-KIF11-HHEX gene locus are reproducibly associated with type 2 diabetes in a Japanese population (2008) J Clin Endocrinol Metab, 93, pp. 310-314Kwak, S.H., Cho, Y.M., Moon, M.K., Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population (2008) Diabetes Res Clin Pract, 79, pp. 284-290Groves, C.J., Wiltshire, S., Smedley, D., Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility (2003) Diabetes, 52, pp. 1300-1305Farris, W., Mansourian, S., Chang, Y., Insulindegrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo (2003) Proc Natl Acad Sci U S A, 100, pp. 4162-4167Farris, W., Mansourian, S., Leissring, M.A., Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein (2004) Am J Pathol, 164, pp. 1425-1434Abdul-Hay, S.O., Kang, D., McBride, M., Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance (2011) PLoS ONE, 6, p. e20818Steneberg, P., Bernardo, L., Edfalk, S., The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of a-synuclein levels in b-cells (2013) Diabetes, 62, pp. 2004-2014Leissring, M.A., Malito, E., Hedouin, S., Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin (2010) PLoS ONE, 5, p. e10504Li, C.Z., Zhang, S.H., Shu, C.D., Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance (2002) Di Yi Jun Yi da Xue Xue Bao, 22, pp. 151-154Di Guglielmo, G.M., Drake, P.G., Baass, P.C., Insulin receptor internalization and signalling (1998) Mol Cell Biochem, 182, pp. 59-63Pivovarova, O., Gögebakan, O., Pfeiffer, A.F., Glucose inhibits the insulin-induced activation of the insulindegrading enzyme in HepG2 cells (2009) Diabetologia, 52, pp. 1656-1664Wiesenthal, S.R., Sandhu, H., McCall, R.H., Free fatty acids impair hepatic insulin extraction in vivo (1999) Diabetes, 48, pp. 766-774Seta, K.A., Roth, R.A., Overexpression of insulin degrading enzyme: Cellular localization and effects on insulin signaling (1997) Biochem Biophys Res Commun, 231, pp. 167-171Auletta, M., Antoniello, S., Abrescia, N., Insulin-degrading activity in experimental liver cirrhosis of the rat (1994) Enzyme Protein, 48, pp. 197-201Sato, H., Terasaki, T., Mizuguchi, H., Receptorrecycling model of clearance and distribution of insulin in the perfused mouse liver (1991) Diabetologia, 34, pp. 613-621Claris, O., Beltrand, J., Levy-Marchal, C., Consequences of intrauterine growth and early neonatal catch-up growth (2010) Semin Perinatol, 34, pp. 207-210Fagerberg, B., Bondjers, L., Nilsson, P., Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: The Atherosclerosis and Insulin Resistance study (2004) J Intern Med, 256, pp. 254-259Cianfarani, S., Germani, D., Branca, F., Low birthweight and adult insulin resistance: The "catch-up growth" hypothesis (1999) Arch Dis Child Fetal Neonatal Ed, 81, pp. F71-F73